During the six-month concept phase, a comprehensive search for attractive cell and gene therapy projects was conducted. The selection of the applications received was based on, among other things, an assessment of the level of innovation, the industrial feasibility and applicability, the industry contribution already acquired to the project, and the hoped-for positive impact on the expansion of the regional industrial sector. The twelve selected projects address current limitations in the field of novel ATMPs, while providing solutions to regulatory and health economic aspects. In addition, the cluster will establish cross-project technical and clinical platforms to support individual projects.